Biocollection
Biocollection is a biological therapy with 10 clinical trials. Currently 5 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
5
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period
Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2
Identifying Biological Markers of Cardiovascular Events in Patients With Aortic Stenosis or TAVI
Cohort of STEMI Patients 2
Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy
Clinical Trials (10)
Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period
Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2
Identifying Biological Markers of Cardiovascular Events in Patients With Aortic Stenosis or TAVI
Cohort of STEMI Patients 2
Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy
Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
PMA-FERTITHEQUE Biocollection
IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima®
Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)
Late Clinical Events Associated With COVID-19 Infection
All 10 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 10